AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME
Clinical trials for AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME trials appear
Sign up with your email to follow new studies for AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare immune disorder: drug targets swollen organs
Disease control Recruiting nowThis study tests a pill called soquelitinib in 15 people aged 16 and older with a rare immune condition called ALPS-FAS. The drug aims to reduce the size of the spleen and lymph nodes, which often become enlarged in this disease. Participants take the pill twice daily for a year,…
Matched conditions: AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 17, 2026 05:30 UTC
-
500-Person study aims to crack the code of autoimmune diseases
Knowledge-focused Recruiting nowThis study is creating a new tool to help doctors diagnose and choose treatments for autoimmune diseases. Researchers will analyze blood samples from 500 children with autoimmune conditions and healthy children to find patterns in genes and other molecules. The goal is to make di…
Matched conditions: AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC